type sequence filename description exhibit text html head title title head body style font time roman time serif style margin nbsp style font time roman time serif margin text align right exhibit style font time roman time serif margin text align right nbsp style font time roman time serif margin confidential portion this document have been redacted omitted pursuant request confidential treatment filed with security exchange commission quot quot pursuant rule under security exchange amended redacted omitted portion indicated with notation ldquo rdquo have been filed separately with style font time roman time serif margin nbsp style font time roman time serif margin text align center license transfer agreement style font time roman time serif margin nbsp style font time roman time serif margin text indent this license transfer agreement ldquo agreement rdquo entered into with effect april ldquo effective date rdquo between pieris pharmaceutical nevada corporation with place business state street floor boston pieris pharmaceutical gmbh german company with place business lise meitner strasse freising germany collectively together with their affiliate ldquo pieris rdquo enumeral biomedical holding delaware corporation with place business cambridgepark drive suite cambridge together with affiliate ldquo enumeral rdquo style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent whereas enumeral posse proprietary technology intellectual property right related certain antibody style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent whereas pieris wish obtain more such antibody development commercialization license intellectual property related such antibody style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent whereas enumeral willing provide such antibody license such intellectual property pieris development commercialization novel compound comprising fusion protein based such antibody oncology style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent therefore consideration mutual covenant promise contained this agreement other good valuable consideration receipt sufficiency which hereby acknowledged party hereto intending legally bound hereby agree follows style font time roman time serif margin nbsp style font time roman time serif margin definition used this agreement following term whether used singular plural shall have following meaning style font time roman time serif margin nbsp style font time roman time serif margin affiliate term ldquo affiliate rdquo shall mean individual corporation association other business entity that directly indirectly control controlled under common control with party question used this definition ldquo affiliate rdquo only term ldquo control rdquo shall mean direct indirect ownership more than fifty percent stock having right vote director thereof ability otherwise control management corporation other business entity whether through ownership voting security contract resolution regulation otherwise style font time roman time serif margin nbsp style font time roman time serif margin anticalin term ldquo anticalin rdquo shall mean whether nucleic acid protein form mutein lipocalin term ldquo mutein rdquo shall mean protein arising result mutation recombinant procedure style font time roman time serif margin nbsp field page sequence option newsection value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center page style width text align right nbsp table style page break before always margin margin bottom style margin nbsp field page style font time roman time serif margin nbsp style font time roman time serif margin commercially reasonable effort term ldquo commercially reasonable effort rdquo shall mean such level effort required carry such obligation manner consistent with effort that pharmaceutical company comparable with pieris would devote same stage development commercialization applicable internally developed therapeutic product similar area with similar market potential similar stage their product life taking into account existence other competitive product market place under development proprietary position product regulatory structure involved intellectual property consideration anticipated profitability product other relevant factor understood that such product potential change from time time based upon changing scientific business marketing return investment consideration avoidance doubt commercially reasonably effort require pieris seek market therapeutic product every country seek obtain regulatory approval every country every potential indication style font time roman time serif margin nbsp style font time roman time serif margin confidential information term ldquo confidential information rdquo mean nonpublic information disclosed oral written electronic other form otherwise learned party receiving such information ldquo recipient rdquo including limited information regarding activity party disclosing such information ldquo discloser rdquo such research development preclinical clinical program data result pharmaceutical biologic candidate product invention work authorship trade secret process conception formula patent patent application license business product marketing sale scientific technical strategy program result including cost price supplier manufacturer customer market data personnel consultant other confidential matter related discloser pieris rsquo confidential information shall specifically include public sequence information provided pieris enumeral anticalin protein lipocalin muteins therapeutic diagnostic information anticalin protein lipocalin muteins including therapeutic drug program derived therefrom information disclosed pieris enumeral relating target molecule anticalin protein provided however that pieris shall disclose information related target molecule anticalin enumeral without prior written consent enumeral ldquo enumeral confidential information rdquo shall confidential information disclosed enumeral ldquo pieris confidential information rdquo shall confidential information disclosed pieris style font time roman time serif margin nbsp style font time roman time serif margin calendar quarter term ldquo calendar quarter rdquo mean each three month period year commencing with january such year style font time roman time serif margin nbsp style font time roman time serif margin definitive agreement term ldquo definitive agreement rdquo shall have meaning forth section style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent developed term ldquo developed rdquo shall have meaning forth section style font time roman time serif margin nbsp style font time roman time serif margin effective date term ldquo effective date rdquo shall have meaning forth first paragraph agreement style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center page style width text align right nbsp table style page break before always margin margin bottom style margin nbsp field page style font time roman time serif margin nbsp style font time roman time serif margin enumeral term ldquo enumeral rdquo shall mean know enumeral owns control with respect first antibody effective date know enumeral owns control with respect subsequent antibody option exercise date defined section patent right enumeral owns control claiming first antibody upon option exercise date subsequent antibody including without limitation patent issuing such patent application substitution extension supplementary protection certificate reissue reexamination renewal division continuation continuation part with respect thereto during term case each clause only such know patent right relate first antibody subsequent antibody method using administrating manufacturing formulating said first subsequent antibody useful necessary pieris develop commercialize product under this agreement patent right effective date listed exhibit style font time roman time serif margin nbsp style font time roman time serif margin exclusive field term ldquo exclusive field rdquo shall mean within field that employ first antibody subsequent antibody fused with linked more anticalin protein style font time roman time serif margin nbsp style font time roman time serif margin field term ldquo field rdquo shall mean therapeutic prophylactic diagnostic palliative diagnosis treatment cancer provided that subject section diagnostic shall limited product shall include service until definitive agreement reached which party intend will provide inclusion diagnostic service within field style font time roman time serif margin nbsp style font time roman time serif margin first antibody term ldquo first antibody rdquo shall mean individually collectively antibody against described exhibit style font time roman time serif margin nbsp style font time roman time serif margin study term ldquo study rdquo mean with respect product study conducted accordance with purpose assessing efficacy safety onset severity duration toxic effect their dose dependency establish profile sufficient support filing investigational drug application style font time roman time serif margin nbsp style font time roman time serif margin good laboratory practice term ldquo good laboratory practice rdquo ldquo rdquo mean then current good laboratory practice standard promulgated endorsed food drug administration case other country territory comparable regulatory standard promulgated endorsed that country including those procedure expressed contemplated regulatory filing style font time roman time serif margin nbsp style font time roman time serif margin infringed patent term ldquo infringed patent rdquo shall mean issued unexpired patent that been abandoned held invalid revoked held rendered unenforceable lost through interference claim which would infringed pieris rsquo making using selling offering sale importing first antibody subsequent antibody portion component thereof case style font time roman time serif margin nbsp style font time roman time serif margin know term ldquo know rdquo shall mean data knowledge information including chemical manufacturing data toxicological data pharmacological data preclinical data formulation specification quality control testing data that necessary useful discovery manufacture development commercialization product existing date this agreement avoidance doubt know include antibody screening technology licensed enumeral from massachusetts institute technology ldquo rdquo further require enumeral provide sample first antibody party will agree writing whether what extent sample subsequent antibody required connection with definitive agreement style font time roman time serif margin text align justify nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center page style width text align right nbsp table style page break before always margin margin bottom style margin nbsp field page style font time roman time serif margin nbsp style font time roman time serif margin text align justify maintenance term ldquo maintenance rdquo shall have meaning forth section style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify major market term major market mean territory north america european union japan style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify marketing authorization term ldquo marketing authorization rdquo ldquo rdquo shall mean shall mean approval license registration authorization including pricing approval necessary sale product market country territory granted competent regulatory authority style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify modification term ldquo modification rdquo mean alteration mutation derivative first antibody subsequent antibody invented conceived reduced practice behalf pieris affiliate sublicensees avoidance doubt modification shall mean first antibody subsequent antibody fused with linked anticalin style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify sale term ldquo sale rdquo shall mean shall mean product particular period style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify gross amount invoiced pieris sale product third party field territory excluding transaction transferring product pieris affiliate sublicensee distributor agent resale following item style font time roman time serif margin text align justify text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width style text align justify customary trade prompt payment quantity cash discount extent actually allowed taken table style font time roman time serif margin text align justify text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width style text align justify amount repaid credited reason rejection recall return table style font time roman time serif margin text align justify text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width style text align justify extent separately stated purchase order invoice other document sale duty tariff other governmental charge levied production sale transportation delivery product table style font time roman time serif margin text align justify text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width style text align justify outbound transportation cost prepaid allowed cost insurance transit table style font time roman time serif margin text align justify text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width style text align justify discount rebate other payment required made under medicaid medicare other governmental special medical assistance program extent actually allowed taken table style font time roman time serif margin text align justify text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width style text align justify amount written reason uncollectible debt exceed sale calendar year table style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify other deduction shall made commission paid individual whether they with independent sale agency regularly employed pieris payroll cost collection product shall considered ldquo sold rdquo ninety after billing invoicing upon receipt payment whichever come first provided however that product actually shipped customer style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent sublicensees sale amount reported calendar quarterly basis pieris accordance with sublicensee contractual term their then currently used accounting standard provided however that such accounting standard consistent with gaap ifrs such other internationally recognized accounting standard agreed party style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center page style width text align right nbsp table style page break before always margin margin bottom style margin nbsp field page style font time roman time serif margin nbsp style font time roman time serif margin party term ldquo party rdquo shall mean pieris enumeral case ldquo party rdquo shall mean pieris enumeral collectively style font time roman time serif margin nbsp style font time roman time serif margin patent right term ldquo patent right rdquo shall mean right under patent patent application country territory including patent issuing such patent application further including substitution extension supplementary protection certificate reissue reexamination renewal division continuation continuation part foregoing style font time roman time serif margin nbsp style font time roman time serif margin phase clinical trial term ldquo phase clinical trial rdquo mean human clinical trial product country that would satisfy requirement style font time roman time serif margin nbsp style font time roman time serif margin phase clinical trial term ldquo phase clinical trial rdquo mean human clinical trial conducted country that would satisfy requirement intended explore more dose response duration effect generate initial evidence clinical activity safety product target patient population style font time roman time serif margin nbsp style font time roman time serif margin phase clinical trial term ldquo phase clinical trial rdquo mean clinical trial extended human patient population designed obtain data determining efficacy safety product support regulatory approval proposed therapeutic indication more fully defined sect successor regulation equivalent foreign country style font time roman time serif margin nbsp style font time roman time serif margin product term ldquo product rdquo shall mean fusion protein formulation containing such fusion protein that constitutes first antibody subsequent antibody modification which first antibody subsequent antibody component portion thereof modification fused with linked least anticalin avoidance doubt product also include first antibody subsequent antibody modification that fused with linked anticalin more additional protein term ldquo product rdquo expressly includes multi specific fusion protein against least unlimited number target style font time roman time serif margin nbsp style font time roman time serif margin royalty term term ldquo royalty term rdquo shall mean with respect product given country period time commencing date first commercial sale product such country ending later date that year after date first commercial sale product such country expiration last expire lapse valid claim patent right owned enumeral filed effective date such country covering import offering sale sale product style font time roman time serif margin nbsp style font time roman time serif margin sublicensee term ldquo sublicensee rdquo shall mean entity which pieris licensed right through multiple tier pursuant this agreement style font time roman time serif margin nbsp style font time roman time serif margin subsequent antibody term ldquo subsequent antibody rdquo shall mean antibody antibody which principally specifically bind target site known owned enumeral other than first antibody that licensed pieris pursuant section will more specifically described exhibit included definitive agreement style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center page style width text align right nbsp table style page break before always margin margin bottom style margin nbsp field page style font time roman time serif margin nbsp style font time roman time serif margin territory term ldquo territory rdquo shall mean country world style font time roman time serif margin nbsp style font time roman time serif margin term term ldquo term rdquo shall have meaning forth section style font time roman time serif margin nbsp style font time roman time serif margin third party term ldquo third party rdquo shall mean party other than pieris enumeral style font time roman time serif margin nbsp style font time roman time serif margin grant license transfer style font time roman time serif margin nbsp style font time roman time serif margin license pieris subject term condition hereof enumeral hereby grant pieris during term currently effective royalty bearing exclusive except exclusive field right license including right sublicense through multiple tier under enumeral research have researched develop have developed register have registered have used make have made import have imported export have exported market have marketed distribute have distributed sold have sold product field territory style font time roman time serif margin nbsp style font time roman time serif margin transfer within payment initial enumeral shall provide pieris full sequence information first antibody relevant know related first antibody described definition enumeral style font time roman time serif margin nbsp style font time roman time serif margin exclusive field until completion royalty payment under section enumeral hereby covenant agrees shall practice exclusive field avoidance doubt during such period time enumeral shall conduct research development effort exclusive field shall file patent application claiming invention exclusive field assist third party doing enumeral further shall license enumeral exclusive field party other than pieris shall applicable include license other agreement restriction prohibiting first antibody subsequent antibody exclusive field enumeral shall remain responsible enforcement this section shall liable breach this section licensee sublicensee enumeral that violate this section notwithstanding foregoing nothing herein shall deemed prevent third party from acquiring enumeral even engaged research development sale lipocalins provided such lipocalins with enumeral during period herein style font time roman time serif margin nbsp style font time roman time serif margin sublicenses pieris shall have right sublicense subcontract through multiple tier without prior consent enumeral provided however that event such sublicensing such sublicensees will subject least same confidentiality diligence obligation pieris hereunder pieris will remain liable term condition this agreement breach sublicensee these term pieris promptly notifies enumeral sublicense along with identity applicable sublicensee sublicenses shall writing pieris shall sublicense first antibody subsequent antibody modification unless part product style font time roman time serif margin nbsp style font time roman time serif margin diligence style font time roman time serif margin nbsp style font time roman time serif margin diligence during term agreement pieris shall commercially reasonable effort develop least product sale least each major market style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center page style width text align right nbsp table style page break before always margin margin bottom style margin nbsp field page style font time roman time serif margin nbsp style font time roman time serif margin payment style font time roman time serif margin nbsp style font time roman time serif margin initial pieris shall enumeral initial which shall upon execution this agreement paid within fifteen effective date style font time roman time serif margin nbsp style font time roman time serif margin maintenance pieris shall enumeral maintenance ldquo maintenance rdquo event that pieris this maintenance agreement shall terminate license under section nbsp shall automatically terminate avoidance doubt payment maintenance shall deemed breach this agreement other than initial forth section pieris shall have further financial obligation enumeral simultaneous with payment maintenance pieris party shall execute full license transfer agreement including customary contractual term that forth right obligation party ldquo definitive agreement rdquo superseding this agreement which party hereby agree diligently negotiate good faith upon execution agreement party fail agree definitive agreement date payment maintenance specified this section pieris elect upon sole discretion maintenance this agreement shall continue govern right obligation party avoidance doubt enumeral shall have right terminate this agreement failure execute definitive agreement moreover failure execute definitive agreement shall affect pieris rsquo enumeral rsquo right under this agreement style font time roman time serif margin nbsp style font time roman time serif margin development milestone payment with respect each first antibody subsequent antibody pieris shall following milestone payment enumeral later occurrence product product achieve each following event occurrence following event corresponding milestone payment with respect payment from sublicensee pieris style font time roman time serif margin nbsp table cellspacing cellpadding style font time roman time serif width border collapse collapse style vertical align bottom width border bottom black solid font style font family time roman time serif font size development event font style vertical align width text align center padding bottom nbsp style vertical align bottom width text align center border bottom black solid font style font family time roman time serif font size product font font style font family time roman time serif font size indication font style vertical align width text align center padding bottom nbsp style vertical align bottom width text align center border bottom black solid font style font family time roman time serif font size product indication font style vertical align width text align center padding bottom nbsp style vertical align bottom width text align center border bottom black solid font style font family time roman time serif font size product indication font style vertical align font style font family time roman time serif font size start study font style text align center nbsp style text align center font style font family time roman time serif font size font style text align center nbsp style text align center font style font family time roman time serif font size font style text align center nbsp style text align center font style font family time roman time serif font size font style vertical align font style font family time roman time serif font size phase clinical trial initiation first person dosing font style text align center nbsp style text align center font style font family time roman time serif font size font style text align center nbsp style text align center font style font family time roman time serif font size font style text align center nbsp style text align center font style font family time roman time serif font size font style vertical align font style font family time roman time serif font size phase clinical trial initiation first patient dosing font style vertical align text align center nbsp style vertical align text align center font style font family time roman time serif font size font style vertical align text align center nbsp rowspan style text align center font style font family time roman time serif font size font rowspan style vertical align text align center nbsp rowspan style text align center font style font family time roman time serif font size font style vertical align font style font family time roman time serif font size phase clinical trial initiation font style text align center nbsp style text align center font style font family time roman time serif font size font style text align center nbsp style vertical align font style font family time roman time serif font size filing font style text align center nbsp style text align center font style font family time roman time serif font size font style text align center nbsp style vertical align font style font family time roman time serif font size other marketing authorization filing font style text align center nbsp style text align center font style font family time roman time serif font size font style text align center nbsp style vertical align font style font family time roman time serif font size other marketing authorization filing font style text align center nbsp style text align center font style font family time roman time serif font size font style text align center nbsp table style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center page style width text align right nbsp table style page break before always margin margin bottom style margin nbsp field page style font time roman time serif margin nbsp table cellspacing cellpadding style font time roman time serif width border collapse collapse style vertical align style width font style font family time roman time serif font size other marketing authorization approval font style width text align center nbsp style width text align center font style font family time roman time serif font size font style width text align center nbsp style width text align center nbsp rowspan style width text align center nbsp rowspan style width text align center nbsp style vertical align font style font family time roman time serif font size other marketing authorization approval font style text align center nbsp style text align center font style font family time roman time serif font size font style text align center nbsp style text align center nbsp style vertical align font style font family time roman time serif font size other marketing authorization approval font style text align center nbsp style text align center font style font family time roman time serif font size font style text align center nbsp style text align center nbsp style vertical align font style font family time roman time serif font size total font style text align center nbsp style text align center font style font family time roman time serif font size font style text align center nbsp style text align center nbsp style vertical align font style font family time roman time serif font size grand total font style text align center nbsp colspan style text align center font style font family time roman time serif font size thirty seven million seven hundred fifty thousand dollar font table style font time roman time serif margin nbsp style font time roman time serif margin avoidance doubt event shall milestone payment paid pieris under this section exceed thirty seven million seven hundred fifty thousand dollar first antibody thirty seven million seven hundred fifty thousand dollar subsequent antibody style font time roman time serif margin nbsp style font time roman time serif margin sale milestone payment with respect each first antibody subsequent antibody pieris shall following sale milestone payment enumeral later occurrence product achieve each following event occurrence following event corresponding milestone payment with respect payment from sublicensee pieris style font time roman time serif margin nbsp table cellspacing cellpadding style font time roman time serif width border collapse collapse style vertical align style width border bottom black solid font style font family time roman time serif font size sale threshold font style width text align center nbsp style width border bottom black solid text align center font style font family time roman time serif font size product font style width text align center nbsp style width border bottom black solid text align center font style font family time roman time serif font size product font style vertical align font style font family time roman time serif font size year with sale font style text align center nbsp style text align center font style font family time roman time serif font size font style text align center nbsp style text align center font style font family time roman time serif font size font style vertical align font style font family time roman time serif font size year with sale font style text align center nbsp style text align center font style font family time roman time serif font size font style text align center nbsp style text align center font style font family time roman time serif font size font style vertical align font style font family time roman time serif font size year with sale font style text align center nbsp style text align center font style font family time roman time serif font size font style text align center nbsp style text align center font style font family time roman time serif font size font style vertical align font style font family time roman time serif font size total font style text align center nbsp style text align center font style font family time roman time serif font size font style text align center nbsp style text align center font style font family time roman time serif font size font style vertical align font style font family time roman time serif font size grand total font style text align center nbsp colspan style text align center font style font family time roman time serif font size sixty seven million five hundred thousand dollar font table style font time roman time serif margin nbsp style font time roman time serif margin avoidance doubt event shall milestone payment paid pieris under this section exceed sixty seven million five hundred thousand dollar first antibody sixty seven million five hundred thousand dollar subsequent antibody sale shall calculated worldwide basis style font time roman time serif margin nbsp style font time roman time serif margin royalty payment during royalty term pieris shall following royalty payment enumeral within time forth section style font time roman time serif margin nbsp table cellspacing cellpadding style font time roman time serif width border collapse collapse style vertical align style width border bottom black solid font style font family time roman time serif font size royalty tier font style width text align center nbsp style width border bottom black solid text align center font style font family time roman time serif font size royalty rate incremental annual sale font style vertical align font style font family time roman time serif font size sale font style text align center nbsp style text align center font style font family time roman time serif font size font style vertical align font style font family time roman time serif font size sale font style text align center nbsp style text align center font style font family time roman time serif font size font style vertical align font style font family time roman time serif font size sale font style text align center nbsp style text align center font style font family time roman time serif font size font style vertical align font style font family time roman time serif font size sale font style text align center nbsp style text align center font style font family time roman time serif font size font table style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center page style width text align right nbsp table style page break before always margin margin bottom style margin nbsp field page style font time roman time serif margin nbsp style font time roman time serif margin royalty payment under this section shall incremental calculated paid product product worldwide basis avoidance doubt royalty term shall country country basis royalty under this section shall paid sale country where royalty term expired style font time roman time serif margin nbsp style font time roman time serif margin royalty payment reduction style font time roman time serif margin nbsp style font time roman time serif margin event that pieris required enter into license other agreement license royalty third party infringed patent royalty payment described section shall reduced amount such third party payment fifty percent royalty payment each calendar year avoidance doubt event shall royalty rate under section reduced more than fifty percent period style font time roman time serif margin nbsp style font time roman time serif margin event that valid patent claim issue from enumeral covering first antibody subsequent antibody country that claim enumeral covering first antibody subsequent antibody subsequently invalidated country then royalty shall reduced duration royalty term country country basis avoidance doubt event shall royalty rate under section reduced more than period style font time roman time serif margin nbsp style font time roman time serif margin subsequent antibody payment enumeral hereby grant pieris exclusive option period ending month after effective date license subsequent antibody owned controlled enumeral order develop commercialize more additional product within field such subsequent antibody shall identified pieris enumeral writing later than time maintenance paid pursuant section pieris wish exercise option pieris shall enumeral within pieris rsquo written notice enumeral election exercise option ldquo option exercise date rdquo described this section within such payment enumeral shall provide pieris full sequence information related know subsequent antibody useful necessary pieris develop commercialize product under this agreement event that pieris make such election definitive agreement this agreement event that there definitive agreement shall apply subsequent antibody mutatis mutandis subsequent antibody first antibody meaning term shall apply addition application term first antibody style font time roman time serif margin nbsp style font time roman time serif margin diagnostic service payment product used connection with diagnostic service party shall negotiate good faith payment structure such service definitive agreement pieris enumeral such payment structure shall view enumeral rsquo third party obligation massachusetts institute technology shall take into account party rsquo desire maintain same overall economic structure forth this agreement style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center page style width text align right nbsp table style page break before always margin margin bottom style margin nbsp field page style font time roman time serif margin nbsp style font time roman time serif margin development commercialization pieris shall solely responsible development commercialization product under this agreement shall have obligation consult with enumeral regarding such development commercialization activity style font time roman time serif margin nbsp style font time roman time serif margin report payment record style font time roman time serif margin nbsp style font time roman time serif margin report payment style font time roman time serif margin nbsp style font time roman time serif margin report within after conclusion each calendar quarter commencing with first calendar quarter which sale generated pieris shall deliver enumeral report containing following information each instance product product basis style font time roman time serif margin nbsp style font time roman time serif margin amount product sold leased otherwise transferred performed pieris affiliate sublicensees applicable calendar quarter style font time roman time serif margin nbsp style font time roman time serif margin gross amount billed invoiced product sold leased otherwise transferred performed pieris affiliate sublicensees during applicable calendar quarter style font time roman time serif margin nbsp style font time roman time serif margin calculation sale applicable calendar quarter style font time roman time serif margin nbsp style font time roman time serif margin total amount payable enumeral dollar sale applicable calendar quarter together with exchange rate used conversion style font time roman time serif margin nbsp style font time roman time serif margin each such quarterly report shall certified behalf pieris chief financial officer true correct complete material respect amount enumeral particular calendar quarter report shall state extent that information described this section received from sublicensee pieris shall required provide such information enumeral shall take action obtain such information style font time roman time serif margin nbsp style font time roman time serif margin payment within later after each calendar quarter after each quarter with respect payment from sublicensee pieris shall enumeral amount with respect sale applicable calendar quarter style font time roman time serif margin nbsp style font time roman time serif margin payment currency payment under this agreement will paid dollar conversion foreign currency dollar will made conversion rate existing united state reported wall street journal last working applicable calendar quarter such payment will without deduction exchange collection other charge style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center page style width text align right nbsp table style page break before always margin margin bottom style margin nbsp field page style font time roman time serif margin nbsp style font time roman time serif margin record pieris shall maintain shall applicable cause affiliate maintain complete accurate record product that sold leased transferred under this agreement amount payable enumeral relation such product which record shall contain sufficient information permit enumeral confirm accuracy report notification delivered enumeral under section pieris affiliate applicable shall retain such record relating given calendar quarter least year after conclusion that calendar quarter during which time enumeral will have right expense cause independent certified public accountant inspect such record pieris during normal business hour purpose verifying accuracy report payment delivered under this agreement pieris rsquo compliance with term hereof such accountant other auditor applicable shall disclose enumeral information other than information relating accuracy report payment delivered under this agreement party shall reconcile underpayment overpayment within after accountant delivers result audit audit performed under this section reveals underpayment excess calendar year pieris shall reimburse enumeral amount incurred connection with such audit avoidance doubt enumeral shall have right audit inspect sublicensee directly audit inspect applicable material received from sublicensee possession pieris pieris however shall audit sublicensees require royalty milestone report connection with sublicense enumeral exercise right under this section only once every month period only with reasonable prior notice style font time roman time serif margin nbsp style font time roman time serif margin late payment payment pieris that paid before date such payment under this agreement will bear interest month interest will accrue beginning first following date payment will compounded quarterly payment such interest pieris shall limit enumeral rsquo right exercise other remedy enumeral have consequence lateness payment style font time roman time serif margin nbsp style font time roman time serif margin payment method each payment enumeral under this agreement shall paid check wire transfer fund enumeral rsquo account accordance with written instruction provided enumeral made wire transfer such payment shall marked refer this agreement style font time roman time serif margin nbsp style font time roman time serif margin withholding similar pieris required withhold amount payable hereunder enumeral applicable country such amount will deducted from payment made pieris remitted appropriate taxing authority benefit enumeral pieris will withhold only such amount required withheld applicable country from which payment being made pieris shall submit enumeral original remittance voucher official receipt evidencing payment corresponding with applicable royalty report pieris will cooperate with enumeral provide such information record enumeral require connection with application enumeral authority country including attempt obtain exemption credit withholding paid country style font time roman time serif margin nbsp style font time roman time serif margin intellectual property style font time roman time serif margin nbsp style font time roman time serif margin product intellectual property pieris shall have right file patent application invention developed direction under sponsorship pieris including limited invention conceived reduced practice pieris employee contractor consultant sublicenses related product material process other intellectual property generated under this agreement including manufacture formulation thereof ldquo developed rdquo avoidance doubt developed includes limited directed sequence product formulation method method manufacture thereof event termination this agreement pieris shall continue such intellectual property style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center page style width text align right nbsp table style page break before always margin margin bottom style margin nbsp field page style font time roman time serif margin nbsp style font time roman time serif margin license enumeral developed that fall outside scope product developed related product including limited product formulation method product method manufacture product target based claim including product exclusive field collectively ldquo grantback rdquo pieris hereby grant enumeral claim claim basis royalty free fully paid exclusive license with right sublicense such claim from grantback sake clarity nothing license granted under this section shall affect scope exclusive field covenant enumeral under section without limiting foregoing pieris file patent application obtains patent containing claim claim directed modification other than modification fused with linked anticalin whether singly more many claim under broader patent then such claim case shall part grantback licensed hereunder including limited composition matter method manufacture vector host cell related thereto style font time roman time serif margin nbsp style font time roman time serif margin liability indemnification style font time roman time serif margin nbsp style font time roman time serif margin indemnity enumeral enumeral shall indemnify defend hold harmless pieris affiliate their respective director officer employee agent their respective successor heir assigns collectively ldquo pieris indemnitees rdquo from against liability damage loss expense including reasonable attorney rsquo expense litigation collectively ldquo loss rdquo incurred imposed upon pieris indemnitees them result claim whitehead institute biomedical research general hospital corporation massachusetts general hospital president fellow harvard college howard hughes medical institute collectively ldquo agreement party rdquo connection with agreement between agreement party enumeral incurred imposed upon pieris indemnitees them direct result claim suit action demand judgment third party arising resulting from breach representation warranty hereunder collectively ldquo pieris indemnity claim rdquo style font time roman time serif margin nbsp style font time roman time serif margin indemnity pieris pieris shall indemnify defend hold harmless enumeral affiliate their respective director officer employee agent their respective successor heir assigns collectively ldquo enumeral indemnitees rdquo against loss incurred imposed upon enumeral indemnitees them direct result claim suit action demand judgment third party arising resulting from development commercialization manufacture product either before after receipt breach representation warranty hereunder collectively ldquo enumeral indemnity claim rdquo style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center page style width text align right nbsp table style page break before always margin margin bottom style margin nbsp field page style font time roman time serif margin nbsp style font time roman time serif margin condition indemnification person seeking recovery under this section ldquo indemnified party rdquo respect claim shall give prompt notice such claim party from whom indemnification sought ldquo indemnifying party rdquo provided that indemnifying party contesting obligation under this section shall permit indemnifying party control litigation relating such claim disposition such claim further provided that indemnifying party shall reasonably good faith with respect matter relating settlement disposition such claim settlement disposition relates such indemnified party settle otherwise resolve such claim without prior written consent such indemnified party which consent shall unreasonably withheld conditioned delayed each indemnified party shall cooperate with indemnifying party defense such claim reasonable respect shall have right present person through counsel legal proceeding with respect such claim indemnifying party assume conduct defense claim provided above indemnified party defend against consent entry judgment enter into settlement with respect such claim manner indemnified party deem reasonably appropriate indemnified party need consult with obtain consent from indemnifying party connection therewith indemnifying party shall remain responsible indemnify indemnified party provided this section style font time roman time serif margin nbsp style font time roman time serif margin insurance each party shall procure maintain insurance including applicable pieris affiliate product liability insurance shall self insure each case manner adequate cover obligation under this agreement consistent with normal business practice prudent company similarly situated time during term period five year thereafter each party shall procure insurance self insure expense understood that such insurance shall construed create limit either party rsquo liability with respect indemnification obligation under this section each party shall provide other party with written evidence such insurance self insurance upon request each party shall provide other party with prompt written notice prior cancellation renewal material change such insurance style font time roman time serif margin nbsp style font time roman time serif margin confidentiality style font time roman time serif margin nbsp style font time roman time serif margin treatment confidential information with respect confidential information discloser recipient agrees such confidential information solely contemplated this agreement including pieris development commercialization more product other purpose hold such confidential information confidence disclose such confidential information others except employee consultant representative require confidential information order carry purpose subject binding obligation confidentiality restricted least protective those this agreement protect confidentiality such confidential information using least same level effort measure used protect valuable confidential information least commercially reasonable effort measure notify discloser promptly practicable unauthorized disclosure such confidential information which recipient becomes aware style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center page style width text align right nbsp table style page break before always margin margin bottom style margin nbsp field page style font time roman time serif margin nbsp style font time roman time serif margin exception confidential treatment obligation section shall apply confidential information that recipient knew before learning under this agreement demonstrated written record predating date learned under this agreement becomes future publicly available except omission recipient third party discloses recipient without restriction disclosure breach confidentiality obligation which such third party subject recipient independently develops without reference confidential information demonstrated recipient rsquo written record contemporaneous with such development style font time roman time serif margin nbsp style font time roman time serif margin required disclosure notwithstanding section recipient disclose discloser rsquo confidential information extent person entity required under applicable governmental rule regulation order provided that recipient first give prompt written notice such disclosure requirement discloser enable discloser seek limitation exemption from such disclosure requirement reasonably cooperates discloser rsquo request such effort discloser style font time roman time serif margin nbsp style font time roman time serif margin ownership confidential information subject section discloser retains right title interest confidential information style font time roman time serif margin nbsp style font time roman time serif margin publicity upon execution this agreement party file form statement attached exhibit disclosure existence term this agreement made either party party shall name trademark trade name logo other party employee publicity promotion news release disclosure relating this agreement subject matter without prior express written permission other party except otherwise forth herein extent required regulation including limited federal state security which prior written permission required with respect filing this agreement with security exchange commission each party will provide other party with reasonable advance notice copy portion such proposed filing which agreement directly relates each party provide comment request regarding proposed confidential treatment agreement term condition agreement case other party will consider reasonable comment request made with respect such filing provided that such comment request consistent with applicable regulation party will agree propose redaction same information confidential treatment application this agreement applicable definitive agreement font style text underline style double font notwithstanding this section each party shall permitted issue later date public filing presentation press release regarding this agreement definitive agreement that contain information from party rsquo form statement attached exhibit applicable enumeral press release attached exhibit style font time roman time serif margin nbsp style font time roman time serif margin ownership information data information generated pieris using enumeral confidential information including limited data information related product shall sole property pieris pieris shall have unlimited right disclose such information information related product whether generated using enumeral confidential information otherwise shall sole property pieris pieris shall have obligation disclose information described this section enumeral style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center page style width text align right nbsp table style page break before always margin margin bottom style margin nbsp field page style font time roman time serif margin nbsp style font time roman time serif margin third party disclosure notwithstanding anything this section either party share existence term this agreement enumeral confidential information related first antibody with third party under obligation confidentiality least restrictive those this agreement defined below without prior consent other party this includes right provide such information potential investor order facilitate investment financing connection with development more product pieris event each party remains subject obligation forth herein style font time roman time serif margin nbsp style font time roman time serif margin prior agreement party have previously entered into mutual confidential disclosure agreement dated october ldquo rdquo material transfer disclosure agreement dated january ldquo rdquo confidential information under this agreement includes public information disclosed connection with extent that there inconsistency this agreement shall supersede style font time roman time serif margin nbsp style font time roman time serif margin term termination style font time roman time serif margin nbsp style font time roman time serif margin term term this agreement shall from effective date absence early termination provided below shall expire upon expiration last expire patent claim from enumeral covering import offering sale sale product style font time roman time serif margin nbsp style font time roman time serif margin termination pieris pieris terminate this agreement time upon thirty rsquo notice style font time roman time serif margin nbsp style font time roman time serif margin termination enumeral enumeral terminate this agreement pieris breach material obligation under this agreement fails cure such breach within sixty thirty with respect breach payment obligation pieris following receipt written notice thereof from enumeral such breach curable within aforesaid period provided however that without limiting application section this agreement there dispute between party connection with such termination under this section shall subject dispute resolution procedure section nbsp style font time roman time serif margin nbsp style font time roman time serif margin termination insolvency party shall have right terminate this agreement entirety upon immediate written notice other party applies consent appointment taking possession receiver custodian trustee liquidator itself substantial part property make general assignment benefit creditor commences voluntary case under bankruptcy code defined below country fails controvert timely appropriate manner acquiesce writing petition filed against involuntary case under bankruptcy code country take corporate action purpose effecting foregoing order relief against entered involuntary case under bankruptcy code country through above application assignment commencement filing corporate action continues unstayed otherwise discharged withdrawn before period sixty style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center page style width text align right nbsp table style page break before always margin margin bottom style margin nbsp field page style font time roman time serif margin nbsp style font time roman time serif margin effect termination event termination this agreement pieris retain shall required provide enumeral with information material related product created developed connection with this agreement including material described section license enumeral shall terminate until definitive agreement reached more distinctly forth party rsquo right post termination pieris shall longer have right develop commercialize product style font time roman time serif margin nbsp style font time roman time serif margin survival following section shall survive termination expiration this agreement extent payment will earned after termination extent payment will earned after termination style font time roman time serif margin nbsp style font time roman time serif margin representation warranty style font time roman time serif margin nbsp style font time roman time serif margin notice infringement enumeral warrant represents that received cease desist letter otherwise been informed third party that infringing intellectual property related first antibody that would otherwise adversely impair pieris rsquo ability develop commercialize product under this agreement style font time roman time serif margin nbsp style font time roman time serif margin conflicting obligation enumeral warrant represents that ability enter into this agreement that agreement with third party including conflict with this agreement style font time roman time serif margin nbsp style font time roman time serif margin mutual representation warranty pieris enumeral each represents warrant other effective date except otherwise noted follows style font time roman time serif margin nbsp style font time roman time serif margin organization corporation company duly organized validly existing good standing under jurisdiction organization requisite power authority corporate otherwise execute deliver perform this agreement style font time roman time serif margin nbsp style font time roman time serif margin authorization execution delivery this agreement performance transaction contemplated hereby have been duly authorized necessary corporate company action will violate such party rsquo certificate incorporation bylaw equivalent organizational document agreement instrument contractual obligation which such party bound material respect requirement applicable order writ judgment injunction decree determination award court governmental agency presently effect applicable such party style font time roman time serif margin nbsp style font time roman time serif margin binding agreement this agreement legal valid binding obligation such party enforceable against accordance with term condition style font time roman time serif margin nbsp style font time roman time serif margin inconsistent obligation under obligation contractual otherwise person that conflict with inconsistent respect with term this agreement that would impede diligent complete fulfillment obligation hereunder style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center page style width text align right nbsp table style page break before always margin margin bottom style margin nbsp field page style font time roman time serif margin nbsp style font time roman time serif margin compliance with during term will comply will ensure that affiliate comply with local state federal international regulation material respect connection with obligation hereunder including with respect pieris those regulation relating development manufacture sale importation product style font time roman time serif margin nbsp style font time roman time serif margin miscellaneous style font time roman time serif margin nbsp style font time roman time serif margin bankruptcy license extent applicable right granted under pursuant this agreement enumeral pieris shall otherwise deemed purpose section title united state code ldquo bankruptcy code rdquo license right ldquo intellectual property rdquo defined under section bankruptcy code party agree that pieris licensee such right under this agreement shall retain fully exercise right election under bankruptcy code style font time roman time serif margin nbsp style font time roman time serif margin limitation damage other than representation warranty forth herein pieris enumeral disclaim other warranty whether express implied with respect each their obligation hereunder including whether more product successfully developed marketed event shall either pieris enumeral liable special indirect incidental consequential damage arising this agreement based contract tort other legal theory style font time roman time serif margin nbsp style font time roman time serif margin dispute resolution event controversy claim counterclaim arising relation this agreement party will first attempt resolve such controversy claim through good faith negotiation between pieris rsquo enumeral rsquo period than thirty following written notification such controversy claim other party such controversy claim resolved mean such negotiation during such period then will finally settled under rule arbitration international chamber commerce more arbitrator appointed accordance with such rule place arbitration will york language used arbitration proceeding will english notwithstanding foregoing nothing shall prevent either party from seeking injunctive other similar equitable relief venue permitted section style font time roman time serif margin nbsp style font time roman time serif margin governing this agreement shall governed construed accordance with york without reference conflict principle subject section party consent exclusive jurisdiction state federal court york event that there dispute related this agreement style font time roman time serif margin nbsp style font time roman time serif margin assignment this agreement assigned transferred either party without prior written consent other party notwithstanding foregoing either party shall have right assign this agreement affiliate third party connection with acquisition consolidation with merger into other corporation other entity person corporate reorganization wherein there change control sale business which this agreement related provided however that such transaction assignee expressly obligates itself written instrument delivered assigning party this agreement before date closing such transaction fully perform obligation assigning party under this agreement nbsp this right assignment shall likewise available assignee same manner assigning party subsequent assignee like manner provided that each instance assignment assignee provides writing specified above assigning party this agreement prior date closing such transaction style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center page style width text align right nbsp table style page break before always margin margin bottom style margin nbsp field page style font time roman time serif margin nbsp style font time roman time serif margin entire understanding this agreement contains entire understanding between party hereto with respect within subject matter supersedes prior agreement understanding arrangement whether written oral style font time roman time serif margin nbsp style font time roman time serif margin unenforceable provision severability provision this agreement held void unenforceable then such void unenforceable provision shall replaced valid enforceable provision that will achieve possible economic business intention party however remainder this agreement will remain full force effect provided that material interest party affected party would presumably have concluded this agreement without unenforceable provision style font time roman time serif margin nbsp style font time roman time serif margin waiver amendment this agreement amended modified superseded canceled term this agreement waived only written instrument executed each party case waiver party party waiving compliance delay failure either party time time require performance exercise right arising provision shall manner affect right later time enforce same waiver party particular provision right shall writing shall particular matter applicable particular period time shall signed such party single partial exercise right power privilege will preclude other further exercise such right power privilege exercise other right power privilege waiver either party condition breach term contained this agreement whether conduct otherwise more instance shall deemed considered further continuing waiver such condition breach such term other term this agreement except expressly forth this agreement right remedy available party whether under this agreement afforded applicable otherwise will cumulative alternative other right remedy that available such party style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center page style width text align right nbsp table style page break before always margin margin bottom style margin nbsp field page style font time roman time serif margin nbsp style font time roman time serif margin text align justify witness whereof party hereto have executed this agreement effective date style font time roman time serif margin text align justify nbsp table cellspacing cellpadding style font time roman time serif width border collapse collapse style vertical align colspan style text align justify font style font family time roman time serif font size pieris pharmaceutical font style text align justify nbsp colspan style text align justify font style font family time roman time serif font size enumeral biomedical holding font style vertical align style width text align justify nbsp style width text align justify nbsp style width text align justify nbsp style width text align justify nbsp style width text align justify nbsp style vertical align style text align justify font style font family time roman time serif font size font style border bottom black solid text align justify font style font family time roman time serif font size stephen yoder font style text align justify nbsp style text align justify font style font family time roman time serif font size font style border bottom black solid text align justify font style font family time roman time serif font size john rydzewski font style vertical align style text align justify nbsp style text align justify nbsp style text align justify nbsp style text align justify nbsp style text align justify nbsp style vertical align style text align justify font style font family time roman time serif font size name font style text align justify font style font family time roman time serif font size stephen yoder font style text align justify nbsp style text align justify font style font family time roman time serif font size name font style text align justify font style font family time roman time serif font size john rydzewski font style vertical align style text align justify nbsp style text align justify nbsp style text align justify nbsp style text align justify nbsp style text align justify nbsp style vertical align style text align justify font style font family time roman time serif font size title font style text align justify font style font family time roman time serif font size president font style text align justify nbsp style text align justify font style font family time roman time serif font size title font style text align justify font style font family time roman time serif font size executive chairman board font style vertical align style text align justify nbsp style text align justify nbsp style text align justify nbsp style text align justify nbsp style text align justify nbsp style vertical align style text align justify font style font family time roman time serif font size date font style text align justify font style font family time roman time serif font size april font style text align justify nbsp style text align justify font style font family time roman time serif font size date font style text align justify font style font family time roman time serif font size april font style vertical align style text align justify nbsp style text align justify nbsp style text align justify nbsp style text align justify nbsp style text align justify nbsp style vertical align colspan style text align justify font style font family time roman time serif font size pieris pharmaceutical gmbh font style text align justify nbsp style text align justify nbsp style text align justify nbsp style vertical align style text align justify nbsp style text align justify nbsp style text align justify nbsp style text align justify nbsp style text align justify nbsp style vertical align style text align justify font style font family time roman time serif font size font style border bottom black solid text align justify font style font family time roman time serif font size stephen yoder font style text align justify nbsp style text align justify nbsp style text align justify nbsp style vertical align style text align justify nbsp style text align justify nbsp style text align justify nbsp style text align justify nbsp style text align justify nbsp style vertical align style text align justify font style font family time roman time serif font size name font style text align justify font style font family time roman time serif font size stephen yoder font style text align justify nbsp style text align justify nbsp style text align justify nbsp style vertical align style text align justify nbsp style text align justify nbsp style text align justify nbsp style text align justify nbsp style text align justify nbsp style vertical align style text align justify font style font family time roman time serif font size title font style text align justify font style font family time roman time serif font size president font style text align justify nbsp style text align justify nbsp style text align justify nbsp style vertical align style text align justify nbsp style text align justify nbsp style text align justify nbsp style text align justify nbsp style text align justify nbsp style vertical align style text align justify font style font family time roman time serif font size date font style text align justify font style font family time roman time serif font size april font nbsp nbsp nbsp table style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center page style width text align right nbsp table style page break before always margin margin bottom style margin nbsp field page style font time roman time serif margin nbsp style font time roman time serif margin text align center exhibit style font time roman time serif margin text align center nbsp style font time roman time serif margin text align center patent right effective date style font time roman time serif margin text align center nbsp style font time roman time serif margin subject matter that pertains first antibody claim example subject matter that would apply different antibody even contained same claim following patent application style font time roman time serif margin nbsp table cellspacing cellpadding style font time roman time serif width border collapse collapse style vertical align style width border bottom black solid patent application style width nbsp style width border bottom black solid filing date style vertical align nbsp nbsp nbsp style vertical align nbsp style vertical align nbsp nbsp nbsp style vertical align nbsp style vertical align nbsp nbsp nbsp style vertical align nbsp style vertical align nbsp nbsp nbsp style vertical align nbsp style vertical align nbsp nbsp nbsp style vertical align nbsp table style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center page style width text align right nbsp table style page break before always margin margin bottom style margin nbsp field page style font time roman time serif margin nbsp style font time roman time serif margin text align center exhibit style font time roman time serif margin text align center nbsp style font time roman time serif margin text align center first antibody description style font time roman time serif margin text align center nbsp style font time roman time serif margin text align center style font time roman time serif margin text align center nbsp style font time roman time serif margin text align center nbsp style font time roman time serif margin text align center style font time roman time serif margin text align center nbsp style font time roman time serif margin text align center style font time roman time serif margin text align center nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center page style width text align right nbsp table style page break before always margin margin bottom style margin nbsp field page style font time roman time serif margin nbsp style font time roman time serif margin text align center exhibit style font time roman time serif margin text align center nbsp style font time roman time serif margin text align center subsequent antibody description style font time roman time serif margin text align center nbsp style font time roman time serif margin text align center completed with definitive agreement style font time roman time serif margin nbsp style font time roman time serif margin enumeral antibody against including humanized chimeric sequence other know generated through option exercise date described with specificity event that both subsequent antibody option exercised style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center page style width text align right nbsp table style page break before always margin margin bottom style margin nbsp field page style font time roman time serif margin nbsp style font time roman time serif margin text align center text indent exhibit style font time roman time serif margin text align center text indent nbsp style font time roman time serif margin text align center text indent pieris enumeral form filing style font time roman time serif margin nbsp style font time roman time serif margin pieris form disclosure style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify april pieris pharmaceutical ldquo company rdquo pieris pharmaceutical gmbh wholly owned subsidiary company together with company ldquo pieris rdquo entered into license transfer agreement ldquo agreement rdquo with enumeral biomedical holding ldquo enumeral rdquo pursuant which pieris acquired exclusive except exclusive field described below worldwide license specified patent right know owned enumeral research develop market fusion protein consisting antibody linked more anticalin protein oncology area enumeral also agreed practice assist third party practicing exclusive field consisting licensed antibody fused anticalin protein oncology area nbsp style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify under agreement pieris agreed enumeral upfront license maintenance nbsp nbsp under initial license pieris also agreed enumeral development milestone aggregate million product indication sale milestone aggregate million product indication nbsp pieris also agreed enumeral royalty within range lower middle single digit percentage sale depending amount sale applicable year nbsp event that pieris required license royalty third party related licensed product royalty payment enumeral shall reduced amount such third party payment royalty payment each calendar year enumeral nbsp style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify under agreement pieris option twelve month after date agreement license from enumeral specified antibody owned enumeral developing such fusion anticalin protein oncology area pieris license additional antibody pursuant option described above pieris must enumeral additional undisclosed upfront payment resulting fusion protein product will subject additional royalty development sale milestone same amount applicable fusion protein linking anticalins under initial license nbsp style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify term agreement upon expiration last expire patent covered under license nbsp nbsp agreement terminated pieris rsquo notice enumeral upon rsquo notice material breach pieris with respect breach payment obligation pieris provided that pieris cured such breach dispute resolution procedure specified agreement have been followed agreement will also automatically terminate pieris elect make maintenance payment described above style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify foregoing description agreement purport complete qualified entirety reference agreement which pieris intends file exhibit quarterly report form quarter ended march style font time roman time serif margin text align justify nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center page style width text align right nbsp table style page break before always margin margin bottom style margin nbsp field page style font time roman time serif margin nbsp style font time roman time serif margin enumeral form disclosure style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify april enumeral biomedical holding with subsidiary ldquo enumeral rdquo ldquo company rdquo entered into license transfer agreement ldquo agreement rdquo with pieris pharmaceutical pieris pharmaceutical gmbh collectively ldquo pieris rdquo pursuant term agreement enumeral granting pieris exclusive royalty bearing worldwide license specified enumeral patent right know research develop market fusion protein consisting enumeral rsquo family anti antibody linked more pieris anticalin protein oncology area enumeral agreed practice assist third party practicing exclusive field consisting licensed antibody fused anticalin protein oncology area nbsp style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify pursuant agreement pieris agreed enumeral upfront initial license agreement also provides that pieris option continue license paying enumeral additional maintenance amount event that pieris this maintenance agreement expires license granted thereunder automatically terminates style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify pieris elect continue license enumeral maintenance agreement provides that pieris shall also receive option twelve month following date agreement license from enumeral specified antibody owned enumeral same term condition enumeral rsquo family anti antibody ldquo subsequent option rdquo event that pieris exercise subsequent option pieris will enumeral additional undisclosed license style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify term agreement provide pieris enumeral development milestone aggregate million upon achievement specified event well sale milestone payment aggregate million upon achievement specified sale threshold nbsp pieris also agrees enumeral royalty lower middle single digit percentage sale depending amount sale applicable year nbsp event that pieris required license royalty third party related licensed product royalty payment enumeral shall reduced amount such third party payment royalty payment each calendar year enumeral nbsp style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify agreement also provides that event pieris license additional antibody pursuant subsequent option resulting fusion protein product will subject additional royalty development sale milestone same amount applicable fusion protein linking anticalins under initial license nbsp style font time roman time serif margin nbsp style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center page style width text align right nbsp table style page break before always margin margin bottom style margin nbsp field page style font time roman time serif margin nbsp style font time roman time serif margin pursuant term agreement enumeral will indemnify pieris indemnitees defined agreement against certain claim specified therein including with respect breach representation warranty well claim massachusetts institute technology other specified entity party agreement with enumeral addition pieris will indemnify enumeral indemnitees defined agreement against certain claim specified therein including with respect breach representation warranty well with respect development commercialization manufacture product before after marketing authorization such term defined agreement agreement also contains customary representation warranty both enumeral pieris style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify term agreement upon expiration last expire patent covered under license nbsp nbsp agreement terminated pieris rsquo notice enumeral upon rsquo notice material breach pieris with respect breach payment obligation pieris provided that pieris cured such breach that dispute resolution procedure specified agreement have been followed agreement will also automatically terminate pieris elect make maintenance payment described above style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center page style width text align right nbsp table style page break before always margin margin bottom style margin nbsp field page style font time roman time serif margin nbsp style font time roman time serif margin text align center exhibit style font time roman time serif margin text align center nbsp style font time roman time serif margin text align center enumeral press release style font time roman time serif margin text align center nbsp style font time roman time serif margin text align center enumeral pieris pharmaceutical enter into style font time roman time serif margin text align center license transfer agreement style font time roman time serif margin text align center nbsp style font time roman time serif margin text align justify cambridge mass mdash april mdash enumeral biomedical holding otcqb enum ldquo enumeral rdquo ldquo company rdquo biotechnology company focused discovering developing novel antibody based immunotherapy help immune system fight cancer other disease today announced that entered into license transfer agreement ldquo license agreement rdquo with pieris pharmaceutical pieris pharmaceutical gmbh collectively ldquo pieris rdquo style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify pursuant term condition license agreement pieris licensing from enumeral specified intellectual property related enumeral rsquo anti antibody program enum potential development commercialization pieris novel multispecific therapeutic protein comprising fusion protein based pieris rsquo anticalins font style font family time roman time serif font class therapeutic protein enumeral antibody field oncology style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify under license agreement pieris agreed enumeral initial license enumeral providing pieris with sequence related information enumeral rsquo family anti antibody license agreement provides that pieris continue license paying enumeral additional maintenance amount event that pieris this maintenance license agreement expires license granted thereunder automatically terminates style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify pieris elect continue license enumeral maintenance license agreement provides that pieris shall also receive exclusive twelve month option license enumeral intellectual property related additional antibody program same term condition enum family anti antibody ldquo subsequent option rdquo antibody subject subsequent option will selected pieris from specified list antibody owned enumeral event that pieris exercise subsequent option pieris will enumeral additional undisclosed license style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify term license agreement provide pieris enumeral development milestone aggregate million upon achievement specified event well sale milestone payment aggregate million upon achievement specified sale threshold under license agreement pieris also agrees enumeral royalty lower middle single digit percentage sale depending amount sale applicable year event that pieris license additional antibody pursuant subsequent option resulting fusion protein product will subject same royalty development sale milestone applicable fusion protein linking anticalins under initial license style font time roman time serif margin text align justify nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center page style width text align right nbsp table style page break before always margin margin bottom style margin nbsp field page style font time roman time serif margin nbsp style font time roman time serif margin text align justify ldquo excited that pieris decided work with antibody sequence encouraged that these sequence could become part novel class therapeutic based pieris rsquo anticalin platform rdquo said cokey nguyen enumeral rsquo vice president research development ldquo enumeral been able generate antibody using proprietary platform technology very efficient manner this transaction further validation enumeral approach look forward working with pieris pursue mutual interest under license agreement rdquo style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify quot gaining access enumeral valuable antibody only enables pieris leverage antibody anticalin multispecifics capability with cornerstone immune checkpoint inhibitor also brings high level intra pipeline synergy including with pieris rsquo lead bispecific immune costimulator candidate quot commented pieris president stephen yoder quot this license give pieris opportunity independently develop anti antibody anticalin multispecific immune checkpoint inhibitor next generation cancer immunotherapeutics quot style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify about enumeral style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify enumeral biopharmaceutical company discovering developing novel antibody immunotherapy that help immune system fight cancer other disease company building pipeline focused next generation checkpoint modulators with initial target including vista developing these agent enumeral rsquo researcher apply proprietary immune profiling technology platform that measure functioning human immune system level individual cell providing insight candidate selection validation more information enumeral please visit enumeral style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify about pieris style font time roman time serif margin nbsp style font time roman time serif margin pieris pharmaceutical clinical stage biotechnology company that discovers develops anticalin based drug target validated disease pathway unique transformative nbsp pieris rsquo pipeline includes immuno oncology multi specific tailored tumor micro environment inhaled anticalin treat uncontrolled asthma half life optimized anticalin treat anemia proprietary pieris anticalins novel class protein therapeutic validated clinic partnership with leading pharmaceutical company nbsp anticalin anticalins registered trademark pieris more information visit nbsp pieris style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center page style width text align right nbsp table style page break before always margin margin bottom style margin nbsp field page style font time roman time serif margin nbsp style font time roman time serif margin text align justify forward looking statement disclosure style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify this press release contains certain ldquo forward looking statement rdquo within meaning private security litigation reform amended such statement reflect current belief enumeral biomedical holding ldquo enumeral rdquo with respect future event involve known unknown risk uncertainty other factor affecting operation market growth enumeral rsquo stock price service product license assurance given regarding achievement future result although enumeral belief that expectation reflected these forward looking statement based reasonable assumption actual result differ from assumption underlying statement that have been made regarding anticipated event factor that cause actual result performance achievement industry result differ materially from those contemplated such forward looking statement include among others risk that enumeral rsquo expectation regarding market acceptance company rsquo business general company rsquo ability penetrate antibody discovery development field particular well timing such acceptance enumeral rsquo ability attract retain management with experience biotechnology antibody discovery similar emerging technology scope validity enforceability enumeral rsquo third party intellectual property right enumeral rsquo ability raise capital when needed acceptable term condition enumeral rsquo ability comply with governmental regulation intensity competition change political regulatory environment business fiscal condition united state overseas general economic condition style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify more detailed information about enumeral risk factor that affect realization forward looking statement including forward looking statement this press release forth enumeral rsquo filing with security exchange commission enumeral urge investor security holder read those document free charge commission rsquo website http forward looking statement speak only date they made except obligation under federal security enumeral undertakes obligation publicly update forward looking statement result information future event otherwise style font time roman time serif margin text align justify nbsp style font time roman time serif margin contact style font time roman time serif margin enumeral biomedical holding kevin sarney kevin enumeral style font time roman time serif margin nbsp field page sequence option last style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center page style width text align right nbsp table field page style font time roman time serif margin nbsp body html text document